Amgen (AMGN)
Latest
-
Dow Boots Exxon, Pfizer, Raytheon in Major Shakeup
blue chip stocks The Dow Jones Industrial Average will replace three of its components, including its longest-serving member, at the end of August.
By Kyle Woodley Published
blue chip stocks -
The 7 Best Biotech Stocks for Investors Who Hate Risk
stocks Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason.
By James Brumley Published
stocks -
7 “Strong Buy” Dividend Stocks That Should Rip Higher
stocks In this current choppy climate, dividend stocks provide a welcome and profitable way to hedge your bets.
By Harriet Lefton Published
stocks -
10 Companies Making Huge Stock Buybacks in 2018
investing For almost two years, investors feared that the wave of stock buybacks that helped drive the market to record highs was finally coming to a close.
By James Brumley Published
investing -
7 Battered Biotech Stocks to Buy While They Are Down
investing Sometimes bad news is good news.
By Nellie S. Huang Published
investing -
Thinking About Buying Gold? Think Again
gold The precious metal makes for a nice anniversary present, but it's not a good investment.
By Bill DeShurko, RIA Published
gold -
The 7 Best Mutual Funds for This Market
investing With Europe on edge, this portfolio emphasizes the two best sectors in a volatile market—and also includes two innovative bond funds.
By Steven Goldberg Published
investing -
Can Amgen Turn Around?
Markets Newsletter editor George Putnam thinks the struggling biotech giant will rebound. He's worth a listen.
By Anne Kates Smith Published
Markets -
Amgen: Biotech Value
Markets Shares of this biotechnology giant have suffered -- yet the company's pipeline and growth strategy look as healthy as ever.
By Staff Published
Markets